Crossmark Global Holdings Inc. Purchases Shares of 26,582 Healthpeak Properties, Inc. (NYSE:DOC)

Crossmark Global Holdings Inc. acquired a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 26,582 shares of the real estate investment trust's stock, valued at approximately $537,000.

Several other institutional investors have also recently made changes to their positions in the stock. Parallel Advisors LLC raised its holdings in shares of Healthpeak Properties by 4.2% during the first quarter. Parallel Advisors LLC now owns 13,980 shares of the real estate investment trust's stock valued at $283,000 after purchasing an additional 561 shares during the period. Townsquare Capital LLC raised its holdings in shares of Healthpeak Properties by 5.9% in the 4th quarter. Townsquare Capital LLC now owns 10,461 shares of the real estate investment trust's stock worth $212,000 after acquiring an additional 584 shares during the last quarter. Huntington National Bank raised its holdings in shares of Healthpeak Properties by 3.0% in the 4th quarter. Huntington National Bank now owns 20,843 shares of the real estate investment trust's stock worth $422,000 after acquiring an additional 613 shares during the last quarter. AssuredPartners Investment Advisors LLC raised its holdings in shares of Healthpeak Properties by 3.1% in the 1st quarter. AssuredPartners Investment Advisors LLC now owns 22,088 shares of the real estate investment trust's stock worth $447,000 after acquiring an additional 666 shares during the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. raised its holdings in shares of Healthpeak Properties by 4.4% in the 4th quarter. Meiji Yasuda Asset Management Co Ltd. now owns 16,649 shares of the real estate investment trust's stock worth $337,000 after acquiring an additional 700 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

Healthpeak Properties Stock Performance

Healthpeak Properties stock traded down $0.10 during mid-day trading on Friday, reaching $18.44. The company's stock had a trading volume of 5,349,015 shares, compared to its average volume of 5,356,732. Healthpeak Properties, Inc. has a 12-month low of $16.64 and a 12-month high of $23.26. The company has a market capitalization of $12.81 billion, a P/E ratio of 46.10, a PEG ratio of 2.10 and a beta of 1.03. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.35 and a current ratio of 1.35. The firm's fifty day moving average price is $17.47 and its two-hundred day moving average price is $18.96.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The business had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. During the same period in the previous year, the business earned $0.45 EPS. Healthpeak Properties's revenue was up 15.9% compared to the same quarter last year. Sell-side analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, September 19th will be paid a $0.1017 dividend. The ex-dividend date is Friday, September 19th. This represents a $1.22 dividend on an annualized basis and a yield of 6.62%. Healthpeak Properties's dividend payout ratio is 305.00%.

Insider Activity at Healthpeak Properties

In other news, Director Tommy G. Thompson purchased 5,777 shares of the business's stock in a transaction on Wednesday, May 28th. The stock was purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the acquisition, the director directly owned 144,290 shares in the company, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Scott M. Brinker purchased 11,337 shares of the business's stock in a transaction on Monday, April 28th. The stock was purchased at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the acquisition, the chief executive officer owned 201,863 shares in the company, valued at approximately $3,568,937.84. This trade represents a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 29,764 shares of company stock worth $521,909. Corporate insiders own 0.23% of the company's stock.

Analyst Upgrades and Downgrades

DOC has been the topic of a number of analyst reports. Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Scotiabank lowered their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a report on Monday, May 12th. Wells Fargo & Company lowered their target price on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a report on Monday, June 2nd. Wedbush lowered their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Finally, Argus restated a "buy" rating and issued a $25.00 target price on shares of Healthpeak Properties in a report on Tuesday, April 29th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and a consensus target price of $23.27.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.